Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives $36.00 Consensus Price Target from Analysts

Smith & Nephew SNATS, Inc. (NYSE:SNN) has been given a consensus rating of “Hold” by the six analysts that are covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $36.00.

SNN has been the subject of several research reports. Wall Street Zen raised Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 30th. Canaccord Genuity Group lifted their target price on Smith & Nephew SNATS from $28.00 to $36.00 and gave the stock a “hold” rating in a report on Monday, August 18th.

Smith & Nephew SNATS Trading Down 2.0%

Shares of Smith & Nephew SNATS stock opened at $37.77 on Friday. The business has a fifty day simple moving average of $34.36 and a two-hundred day simple moving average of $30.47. Smith & Nephew SNATS has a 1 year low of $23.69 and a 1 year high of $38.79. The company has a market capitalization of $16.45 billion, a price-to-earnings ratio of 17.49, a P/E/G ratio of 1.04 and a beta of 0.70. The company has a debt-to-equity ratio of 0.60, a current ratio of 3.00 and a quick ratio of 1.40.

Smith & Nephew SNATS Cuts Dividend

The company also recently announced a semi-annual dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 3rd will be issued a dividend of $0.285 per share. The ex-dividend date of this dividend is Friday, October 3rd. This represents a dividend yield of 210.0%. Smith & Nephew SNATS’s dividend payout ratio (DPR) is currently 41.20%.

Institutional Investors Weigh In On Smith & Nephew SNATS

Hedge funds and other institutional investors have recently modified their holdings of the company. Hexagon Capital Partners LLC lifted its holdings in shares of Smith & Nephew SNATS by 63.3% during the first quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 406 shares in the last quarter. Richards Merrill & Peterson Inc. raised its stake in Smith & Nephew SNATS by 500.0% in the first quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 1,000 shares in the last quarter. AlphaCore Capital LLC acquired a new position in Smith & Nephew SNATS in the second quarter valued at about $44,000. Bessemer Group Inc. raised its stake in Smith & Nephew SNATS by 3,471.4% in the first quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider’s stock valued at $49,000 after purchasing an additional 1,701 shares in the last quarter. Finally, Banque Transatlantique SA acquired a new position in Smith & Nephew SNATS in the first quarter valued at about $52,000. Institutional investors and hedge funds own 25.64% of the company’s stock.

About Smith & Nephew SNATS

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.